
The OptiLUTS trial : improving care for therapy-resistant symptoms of the pelvis in Belgium
- Author
- Lynn Ghijselings (UGent) , Dirk Van de Putte (UGent) , François Hervé (UGent) , An-Sofie Goessaert (UGent) , Dimitri Beeckman (UGent) , Piet Pattyn (UGent) and Karel Everaert (UGent)
- Organization
- Abstract
- Introduction/Background: The management of therapy-resistant lower urinary tract symptoms (LUTS) and symptoms resulting from pelvic organ dysfunctions are subject to a high variability in the Belgian health-care centres. Practical guidelines and standardized patient clinical care pathways are often lacking and unadapted to the Belgian healthcare system. Objectives: The OptiLUTS trial aims to improve the multidisciplinary care of therapy-resistant symptoms of the pelvis in the Belgian healthcare setting. Project A aims for the improvement of knowledge of 2nd line treatments for LUTS among general practitioners. In project B a treatment algorithm for the overactive bladder syndrome and non-obstructive urinary retention will be developed specifically for Belgium. In Project C a patient customized sacral neuromodulation (SNM) care pathway will be set up. Methods: Part A: Explorative study among general practitioners by distribution of a questionnaire. Part B: Review of existing guidelines and use of the Delphi method to obtain expert consensus. Part C: A single center comparative study to compare outcomes before and after implementation of the SNM care pathway. Patients scheduled for the first stage of Interstim therapy (TM) will be included (N=100). Primary endpoints are the sensitivity and specificity of a new pelvic symptom assessment tool, the conversion to implant and explantation rates. Conclusion: There is a margin for improvement in the care process of patients with therapy-resistant symptoms of the pelvis in the Belgium healthcare system. In the OptiLUTs trial adapted guidelines and a clinical care pathway will be developed to standardize and increase the efficiency of care.
- Keywords
- General Medicine, Lower urinary tract symptoms, Clinical care pathway, Sacral neuromodulation, Overactive bladder, Quality Improvement, QUALITY-OF-LIFE, SACRAL NEUROMODULATION, SCORING SYSTEM, QUESTIONNAIRE, IMPACT, INDEX, ICIQ
Downloads
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 1.14 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8669635
- MLA
- Ghijselings, Lynn, et al. “The OptiLUTS Trial : Improving Care for Therapy-Resistant Symptoms of the Pelvis in Belgium.” ACTA CLINICA BELGICA, vol. 75, no. 5, 2020, pp. 334–39, doi:10.1080/17843286.2019.1630109.
- APA
- Ghijselings, L., Van de Putte, D., Hervé, F., Goessaert, A.-S., Beeckman, D., Pattyn, P., & Everaert, K. (2020). The OptiLUTS trial : improving care for therapy-resistant symptoms of the pelvis in Belgium. ACTA CLINICA BELGICA, 75(5), 334–339. https://doi.org/10.1080/17843286.2019.1630109
- Chicago author-date
- Ghijselings, Lynn, Dirk Van de Putte, François Hervé, An-Sofie Goessaert, Dimitri Beeckman, Piet Pattyn, and Karel Everaert. 2020. “The OptiLUTS Trial : Improving Care for Therapy-Resistant Symptoms of the Pelvis in Belgium.” ACTA CLINICA BELGICA 75 (5): 334–39. https://doi.org/10.1080/17843286.2019.1630109.
- Chicago author-date (all authors)
- Ghijselings, Lynn, Dirk Van de Putte, François Hervé, An-Sofie Goessaert, Dimitri Beeckman, Piet Pattyn, and Karel Everaert. 2020. “The OptiLUTS Trial : Improving Care for Therapy-Resistant Symptoms of the Pelvis in Belgium.” ACTA CLINICA BELGICA 75 (5): 334–339. doi:10.1080/17843286.2019.1630109.
- Vancouver
- 1.Ghijselings L, Van de Putte D, Hervé F, Goessaert A-S, Beeckman D, Pattyn P, et al. The OptiLUTS trial : improving care for therapy-resistant symptoms of the pelvis in Belgium. ACTA CLINICA BELGICA. 2020;75(5):334–9.
- IEEE
- [1]L. Ghijselings et al., “The OptiLUTS trial : improving care for therapy-resistant symptoms of the pelvis in Belgium,” ACTA CLINICA BELGICA, vol. 75, no. 5, pp. 334–339, 2020.
@article{8669635, abstract = {{Introduction/Background: The management of therapy-resistant lower urinary tract symptoms (LUTS) and symptoms resulting from pelvic organ dysfunctions are subject to a high variability in the Belgian health-care centres. Practical guidelines and standardized patient clinical care pathways are often lacking and unadapted to the Belgian healthcare system. Objectives: The OptiLUTS trial aims to improve the multidisciplinary care of therapy-resistant symptoms of the pelvis in the Belgian healthcare setting. Project A aims for the improvement of knowledge of 2nd line treatments for LUTS among general practitioners. In project B a treatment algorithm for the overactive bladder syndrome and non-obstructive urinary retention will be developed specifically for Belgium. In Project C a patient customized sacral neuromodulation (SNM) care pathway will be set up. Methods: Part A: Explorative study among general practitioners by distribution of a questionnaire. Part B: Review of existing guidelines and use of the Delphi method to obtain expert consensus. Part C: A single center comparative study to compare outcomes before and after implementation of the SNM care pathway. Patients scheduled for the first stage of Interstim therapy (TM) will be included (N=100). Primary endpoints are the sensitivity and specificity of a new pelvic symptom assessment tool, the conversion to implant and explantation rates. Conclusion: There is a margin for improvement in the care process of patients with therapy-resistant symptoms of the pelvis in the Belgium healthcare system. In the OptiLUTs trial adapted guidelines and a clinical care pathway will be developed to standardize and increase the efficiency of care.}}, author = {{Ghijselings, Lynn and Van de Putte, Dirk and Hervé, François and Goessaert, An-Sofie and Beeckman, Dimitri and Pattyn, Piet and Everaert, Karel}}, issn = {{1784-3286}}, journal = {{ACTA CLINICA BELGICA}}, keywords = {{General Medicine,Lower urinary tract symptoms,Clinical care pathway,Sacral neuromodulation,Overactive bladder,Quality Improvement,QUALITY-OF-LIFE,SACRAL NEUROMODULATION,SCORING SYSTEM,QUESTIONNAIRE,IMPACT,INDEX,ICIQ}}, language = {{eng}}, number = {{5}}, pages = {{334--339}}, title = {{The OptiLUTS trial : improving care for therapy-resistant symptoms of the pelvis in Belgium}}, url = {{http://dx.doi.org/10.1080/17843286.2019.1630109}}, volume = {{75}}, year = {{2020}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: